Top Summary
This bill amends several federal acts to enhance opioid recovery efforts, including modifying coordination requirements for comprehensive opioid recovery centers, adding reporting obligations for entities using referrals or contracts, restructuring subsection (h) for clarity, and extending the reporting period from 2019–2023 to 2026–2030. It also extends the deadline for addressing the economic and workforce impacts of the opioid crisis from 2023 to 2030 and amends the Controlled Substances Act to limit pharmacies' ability to deliver certain controlled substances to practitioners, restricting this to specific schedules and administration methods requiring post-administration monitoring.